Catherine Novack Analyst PerformanceAnalyst at UBS GroupCatherine Novack is a stock analyst at UBS Group in the healthcare sector, covering 12 publicly traded companies. Over the past year, Catherine Novack has issued 10 stock ratings, including buy and hold recommendations. While full access to Catherine Novack's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Catherine Novack's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings15 Last 1 YearsBuy Recommendations80.00% 12 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution15RatingsDistribution of strong buy, buy, hold, and sell ratings by Catherine Novack.RatingPercentageCount Strong Buy0.0%0 ratings Buy80.0%12 ratings Hold20.0%3 ratings Sell0.0%0 ratingsOut of 15 total stock ratings issued by Catherine Novack at UBS Group, the majority (80.0%) have been Buy recommendations, followed by 20.0% Hold.Best & Worst CallsBest Call0000.0%PVLAMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%FEMYMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ12 companiesCatherine Novack, an analyst at UBS Group, currently covers 12 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare12 companies100.0%Catherine Novack of UBS Group specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY10 companies83.3%PHARMACEUTICALS1 company8.3%HEALTHCARE EQUIPMENT & SUPPLIES1 company8.3% Catherine Novack's Ratings History at UBS Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSEPNSepterna8/13/2026Boost Price Target$45.41$62.00Buy$0.0000.00% ROICAPRCapricor Therapeutics7/31/2026Downgrade$4.19Hold$0.0000.00% ROIPRQRProQR Therapeutics6/26/2026Lower Price Target$1.54$10.00Buy$0.0000.00% ROISPRBSpruce Biosciences6/9/2026Initiated Coverage$49.32$135.00Buy$0.0000.00% ROIDTILPrecision BioSciences4/17/2026Reiterated Rating$7.69$30.00Buy$0.0000.00% ROIIBIOiBio3/3/2026Initiated Coverage$2.69$7.00Buy$0.0000.00% ROISEPNSepterna12/23/2025Initiated Coverage$29.47$43.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics12/15/2025Reiterated Rating$87.89$143.00Buy$0.0000.00% ROIKRROKorro Bio11/14/2025Downgrade$6.50Hold$0.0000.00% ROIAARDAardvark Therapeutics10/1/2025Initiated Coverage$13.29$33.00Buy$0.0000.00% ROIDYNDyne Therapeutics6/26/2025Initiated Coverage$10.42$30.00Buy$00.0000.00% ROICAPRCapricor Therapeutics6/25/2025Lower Price Target$9.25$29.00Buy$00.0000.00% ROIFEMYFemasys5/13/2025Lower Price Target$22.00$120.00Buy$0.0000.00% ROIRLYBRallybio4/15/2025Reiterated Rating$0.27Hold$0.0000.00% ROIPVLAPalvella Therapeutics3/25/2025Initiated Coverage$27.87$45.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupUBS GroupBMO Capital MarketsStifel NicolausCantor FitzgeraldSanford C. BernsteinWall Street ZenBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD Cowen Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
